People taking semaglutide had a 24% lower risk of major kidney events, including kidney failure, sustained eGFR decline, and kidney-related death
Supports a healthy GI system*
But as this new era unfolds, concerns about side effects, cost and access have emerged
The Endocrine Society has highlighted the importance of physical activity and protein intake for patients using GLP-1 medications, especially to help protect muscle during weight loss
Your healthcare provider can help you map out a timeline, decide what to do if weight starts to creep back, and choose other options if needed
[9] [10] Alternatives: Non-pharmacologic interventions or alternative therapies may be considered for lactating patients requiring GH modulation